Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses S2k Guideline of the German Respiratory Society.
Respiration
; : 1-43, 2024 Sep 09.
Article
en En
| MEDLINE
| ID: mdl-39250885
ABSTRACT
Interstitial lung diseases (ILD) are characterized by a variable degree of inflammatory and fibrotic changes within the alveolar space and distal airways (bronchioles). An inverse correlation exists between the extent of fibrosis and the possibility that an ILD is reversible. While the acute (inflammatory) type of extrinsic allergic alveolitis may resolve without sequelae (restitutio ad integrum), IPF is the prototypic fibrotic ILD with a progressive course, leading to an irreversible and progressive fibrosis of the lung parenchyma. This guideline provides guidance on differnential pharmacological treatment approaches to different types of fibrotic interstitial lung diseases.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Respiration
Año:
2024
Tipo del documento:
Article